Curative raised over $150 million in series B funding, bringing its valuation to $1.275 billion, according to a Dec. 2 news release.
The startup, formerly a COVID-19 testing company, offers health insurance plans with no out-of-pocket costs — as long as members attend an annual preventive health visit — in Texas, Florida and Georgia.
The capital infusion will help the insurer scale across the country, first focusing on Mid-Atlantic states. Curative also plans to invest in member engagement, AI-enhanced capabilities and network development.
“The healthcare industry is notoriously challenging with so many misaligned incentives. To see Curative successfully setting a new standard for employer-based health insurance that actually makes people healthier — wow, that has been exhilarating,” said Chris Anderson, managing partner at Upside Vision Fund, who led the latest funding round.
Curative serves over 1,200 employer clients and 165,000 members.
